Contact
searchSearch
HMP Global
Login

Health Economics and Outcomes Research Topic Center

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
Conference Coverage
Hospital Costs and Health Care Resource Utilization for Chimeric Antigen T-Cell Therapy and Stem Cell Transplant in Patients with Large B-Cell Lymphoma in the United States
12/12/2022
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting...
12/12/2022
Journal of Clinical Pathways
Conference Coverage
Cost-Related Medication Nonadherence Among Cancer Survivors in Rural and Urban Settings
10/04/2021
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented at the 2021 ASCO Quality Care Symposium, cost-related prescription nonadherence is associated with higher health care cost responsibility in cancer survivors, especially for those living in rural compared to...
According to a study presented...
10/04/2021
Journal of Clinical Pathways
The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
Pharma Insights
The Importance of Qualitative Research in Enhancing Understanding of Treatment Decisions, Outcomes, and Value Assessment
05/19/2021
Suepattra May, MPH, PhD, and colleagues believe upfront qualitative research conducted directly with stakeholders is needed to generate both a baseline understanding of the patient perspective and to identify the appropriate themes and...
Suepattra May, MPH, PhD, and colleagues believe upfront qualitative research conducted directly with stakeholders is needed to generate both a baseline understanding of the patient perspective and to identify the appropriate themes and...
Suepattra May, MPH, PhD, and...
05/19/2021
Journal of Clinical Pathways
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
We Have Vaccines, Now What? How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access
02/22/2021
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
Abstract: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines,...
...
02/22/2021
Journal of Clinical Pathways

Expert Insights

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Stephen Edge, MD.
Videos
Clinical Pathways in Practice at Roswell Park Cancer Center
09/05/2023
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president for system quality and outcomes at the Roswell Park Comprehensive Cancer Center and the University of Buffalo in Buffalo, New York, spoke with the Journal of Clinical Pathways about his experience using...
Stephen Edge, MD, vice president...
09/05/2023
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Interview
Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways
02/13/2017
JCP Editors
Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...
Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...
...
02/13/2017
Journal of Clinical Pathways
Sawsan Rashdan, MD
Videos
Future Directions in NSCLC Care: Navigating Pathways, Costs, and Cutting-Edge Therapies
11/14/2024
Dr. Sawsan Rashdan, an associate professor at UT Southwestern Medical Center specializing in lung cancer, discusses the transformative impact of targeted therapies and immunotherapies on NSCLC treatment.
Dr. Sawsan Rashdan, an associate professor at UT Southwestern Medical Center specializing in lung cancer, discusses the transformative impact of targeted therapies and immunotherapies on NSCLC treatment.
Dr. Sawsan Rashdan, an associate...
11/14/2024
Journal of Clinical Pathways
Videos
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
11/12/2024
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD,...
11/12/2024
Journal of Clinical Pathways
Kerry Rogers, MD
Videos
Assessing Fixed-Duration Obinutuzumab, Ibrutinib, and Venetoclax in CLL: A 7-Year Follow-Up
11/08/2024
Kerry Rogers, MD, provides a 7-year update on her study that evaluated the progression-free survival and factors associated with undetectable minimal residual disease status after treatment with a fixed-duration combination of obinutuzumab,...
Kerry Rogers, MD, provides a 7-year update on her study that evaluated the progression-free survival and factors associated with undetectable minimal residual disease status after treatment with a fixed-duration combination of obinutuzumab,...
Kerry Rogers, MD, provides a...
11/08/2024
Journal of Clinical Pathways
BDHC Thumbnail
Breaking Down Health Care
Navigating Payer Challenges in Cell and Gene Therapy
11/07/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the challenges and potential solutions for integrating cell and gene therapies—particularly CAR T—into clinical practice and insurance...
In this Breaking Down Health...
11/07/2024
Cancer Care Business Exchange
Videos
Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships
11/04/2024
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Videos
Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care
11/01/2024
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice...
11/01/2024
Journal of Clinical Pathways
Interview
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
10/30/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
10/30/2024
Journal of Clinical Pathways
JB
Interview
The Road Ahead for CLL Research and Treatment: Overcoming Challenges and Embracing Innovations in Patient Care
10/25/2024
Learn about recent advancements in CLL treatment including the potential approval of new combination therapies and the evolving landscape of targeted therapies.
Learn about recent advancements in CLL treatment including the potential approval of new combination therapies and the evolving landscape of targeted therapies.
Learn about recent advancements...
10/25/2024
Journal of Clinical Pathways
Jessica Paulus, ScD
Interview
Insights on Lung Cancer Diagnosis Trends and Screening Challenges in Community Oncology
10/23/2024
In this interview, Jessica Paulus, ScD, senior director of real-world research at Ontada, discusses trends in advanced non–small cell and small cell lung cancer diagnoses, the impact of the COVID-19 pandemic on screening, and the need for...
In this interview, Jessica Paulus, ScD, senior director of real-world research at Ontada, discusses trends in advanced non–small cell and small cell lung cancer diagnoses, the impact of the COVID-19 pandemic on screening, and the need for...
In this interview, Jessica...
10/23/2024
Journal of Clinical Pathways
Federico Cappuzzo, MD, National Cancer Institute Regina Elena
Videos
The Impact of Subcutaneous Formulation of Atezolizumab on Treatment for Patients with Non-Small Cell Lung Cancer
10/17/2024
Federico Cappuzzo, MD, discusses the benefits of the subcutaneous formulation of atezolizumab compared with the intravenous route.
Federico Cappuzzo, MD, discusses the benefits of the subcutaneous formulation of atezolizumab compared with the intravenous route.
Federico Cappuzzo, MD, discusses...
10/17/2024
Oncology

Newsfeed

News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
Conference Coverage
Hospital Costs and Health Care Resource Utilization for Chimeric Antigen T-Cell Therapy and Stem Cell Transplant in Patients with Large B-Cell Lymphoma in the United States
12/12/2022
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting...
12/12/2022
Journal of Clinical Pathways
News
ICER Use of Real-World Evidence in Scoping Process and Clinical Evidence Assessments
01/13/2021
01/13/2021
Journal of Clinical Pathways
News
Do ICER Methodologies Align With Established Research Standards?
01/13/2021
01/13/2021
Journal of Clinical Pathways
News
AACI Clinical Research Innovation Committee Survey Evaluates Complexity of Clinical Trials Offices
01/05/2021
01/05/2021
Journal of Clinical Pathways
News
Care Model Beneficial for Estimating Impact of MM Treatment on Payers
09/22/2020
09/22/2020
Journal of Clinical Pathways
News
Analysis Explores Economic Burden of Ovarian Cancer in Commercially Insured Population
08/18/2020
Working-age patients with metastatic ovarian cancer experience significantly higher costs compared to those without cancer, according to findings from an analysis published in the Journal of Managed Care &...
Working-age patients with metastatic ovarian cancer experience significantly higher costs compared to those without cancer, according to findings from an analysis published in the Journal of Managed Care &...
...
08/18/2020
Journal of Clinical Pathways
News
Economic, Clinical Burden of AML Treatment Episodes in Commercially Insured Patients
07/02/2020
A new retrospective analysis highlights a “substantial economic burden” associated with key acute myeloid leukemia (AML) treatment episodes in commercially insured patients. Results of the analysis were published in...
A new retrospective analysis highlights a “substantial economic burden” associated with key acute myeloid leukemia (AML) treatment episodes in commercially insured patients. Results of the analysis were published in...
A new...
07/02/2020
Journal of Clinical Pathways
News
Enhancing Survival in Endometrial Cancer: Impact of Immunotherapy and Chemotherapy Combination Therapy
11/13/2024
Combining immunotherapy with chemotherapy in the treatment of advanced endometrial cancer, particularly in cases of mismatch repair deficiency, has shown promising results in improving progression-free and overall survival outcomes according...
Combining immunotherapy with chemotherapy in the treatment of advanced endometrial cancer, particularly in cases of mismatch repair deficiency, has shown promising results in improving progression-free and overall survival outcomes according...
Combining immunotherapy with...
11/13/2024
Journal of Clinical Pathways
News
Under 50% of Oncology Practices Offer Survivorship Clinics
11/12/2024
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice groups offer a general survivorship clinic for cancer survivors, according to a study published online in JNCI Cancer Spectrum.
Just 41% of oncology practice...
11/12/2024
Journal of Clinical Pathways
News
Experts Reach Consensus on Myelofibrosis Management, Offering New Hope for Patients
11/08/2024
A comprehensive international consensus program has provided vital clinical recommendations to enhance the treatment landscape for myelofibrosis (MF).
A comprehensive international consensus program has provided vital clinical recommendations to enhance the treatment landscape for myelofibrosis (MF).
A comprehensive international...
11/08/2024
Journal of Clinical Pathways
News
Advancing Personalized Treatment in Endometrial Cancer With the HECTOR Deep Learning Model
11/06/2024
According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...
According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...
According to a study published...
11/06/2024
Journal of Clinical Pathways
News
Influence of Socioeconomic and Demographic Factors on Myelofibrosis Outcomes
10/30/2024
Addressing socioeconomic disparities may improve survival for patients with myelofibrosis, according to a study published in Annals of Hematology.
Addressing socioeconomic disparities may improve survival for patients with myelofibrosis, according to a study published in Annals of Hematology.
Addressing socioeconomic...
10/30/2024
Journal of Clinical Pathways
News
Hypertension and Endometrial Cancer Risk: A Systematic Review and Meta-Analysis
10/25/2024
A systematic review and meta-analysis found a significant association between hypertension and an increased risk of endometrial cancer.
A systematic review and meta-analysis found a significant association between hypertension and an increased risk of endometrial cancer.
A systematic review and...
10/25/2024
Journal of Clinical Pathways
News
Harnessing the Potential of Abemaciclib in Recurrent Endometrial Cancer Treatment
10/25/2024
Abemaciclib, a CDK4/6 inhibitor used in breast cancer treatment, shows promise in targeting novel mechanisms in endometrial cancer for potential therapeutic benefits in cases of recurrence, particularly in estrogen receptor-positive patients.
Abemaciclib, a CDK4/6 inhibitor used in breast cancer treatment, shows promise in targeting novel mechanisms in endometrial cancer for potential therapeutic benefits in cases of recurrence, particularly in estrogen receptor-positive patients.
Abemaciclib, a CDK4/6 inhibitor...
10/25/2024
Journal of Clinical Pathways
News
Pembrolizumab Plus Adjuvant Chemotherapy for Newly Diagnosed High-Risk dMMR Endometrial Cancer
10/21/2024
Pembrolizumab combined with adjuvant carboplatin-paclitaxel significantly improves disease-free survival in patients with high-risk mismatch repair-deficient endometrial cancer, according to a study published in the Journal of Clinical...
Pembrolizumab combined with adjuvant carboplatin-paclitaxel significantly improves disease-free survival in patients with high-risk mismatch repair-deficient endometrial cancer, according to a study published in the Journal of Clinical...
Pembrolizumab combined with...
10/21/2024
Journal of Clinical Pathways
News
False Negatives More Prevalent in Endometrial Cancer Screening for Black Women
10/17/2024
A study published in JAMA Oncology found that Black women are more likely to receive false negative results from transvaginal ultrasounds for endometrial cancer compared to White women, highlighting the need for improved diagnostic methods...
A study published in JAMA Oncology found that Black women are more likely to receive false negative results from transvaginal ultrasounds for endometrial cancer compared to White women, highlighting the need for improved diagnostic methods...
A study published in JAMA...
10/17/2024
Journal of Clinical Pathways
News
Efficacy of Momelotinib in Managing Anemia in Myelofibrosis: Results from the SIMPLIFY-2 Trial
10/16/2024
A study published in Advances in Therapy shows that momelotinib significantly improves anemia and related symptoms in patients with myelofibrosis, particularly those previously treated with ruxolitinib.
A study published in Advances in Therapy shows that momelotinib significantly improves anemia and related symptoms in patients with myelofibrosis, particularly those previously treated with ruxolitinib.
A study published in Advances in...
10/16/2024
Journal of Clinical Pathways

Research in Review

Research in Review
Costs and Complications Associated With Repeated Breast-Conserving Surgery for Breast Cancer
08/09/2017
JCP Editors
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications, according...
More...
08/09/2017
Journal of Clinical Pathways
Research in Review
Comparing Prognostic Values of MRI or PET-CT at Multiple Myeloma Diagnosis
07/12/2017
JCP Editors
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma, published in the Journal of Clinical Oncology (published online July 7, 2017;...
...
07/12/2017
Journal of Clinical Pathways
Research in Review
Intensified Regimens More Effective Than Standard Therapy in DLBCL
06/28/2017
JCP Editors
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
Cost-Effective Substitute for Breast Cancer MRI Identified
06/26/2017
JCP Editors
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...
A...
06/26/2017
Journal of Clinical Pathways
Research in Review
DLBCL Survival Outcomes Improved With Combination Therapy
06/22/2017
JCP Editors
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
Reducing Cancer Drug Waste May Lead to Significant Cost Savings
06/13/2017
JCP Editors
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...
...
06/13/2017
Journal of Clinical Pathways
Research in Review
Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing
05/31/2017
JCP Editors
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...
Women...
05/31/2017
Journal of Clinical Pathways
Research in Review
Cost-Effectiveness of Early-Stage Breast Cancer Treatment Options Vary Significantly
04/21/2017
JCP Editors
Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...
Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...
...
04/21/2017
Journal of Clinical Pathways
Research in Review
Cost-Related Medication Non-Adherence More Likely Among Certain Patients
12/29/2016
JCP Editors
A new study sheds light on factors that make it more likely patients with cancer will not adhere to their treatment because of cost reasons. ----- Related Content Cognitive Factors Linked to Treatment Adherence in...
A new study sheds light on factors that make it more likely patients with cancer will not adhere to their treatment because of cost reasons. ----- Related Content Cognitive Factors Linked to Treatment Adherence in...
A new...
12/29/2016
Journal of Clinical Pathways
Research in Review
Study Identifies Steep Price Hikes for Older Cancer Drugs
10/17/2016
JCP Editors
The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...
The rising cost of cancer drugs continues to draw criticism from leading academic researchers, and threatens health care budgets. In a new study, researchers found that the price of older drugs increased more in a...
The...
10/17/2016
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Cancer
06/16/2022
JCP Editors
J Clin Pathways. 2022;8(5):12. Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients With Advanced Cancer Who Were Near the End of Life Immune checkpoint inhibitors (ICIs) have revolutionized the...
J Clin Pathways. 2022;8(5):12. Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients With Advanced Cancer Who Were Near the End of Life Immune checkpoint inhibitors (ICIs) have revolutionized the...
J Clin Pathways....
06/16/2022
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Ovarian Cancer
05/20/2022
JCP Editors
J Clin Pathways. 2022;8(4):8-11. Progression-Free Survival Associated With Olaparib With or Without Cediranibvs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer Study findings suggest that neither olaparib monotherapy...
J Clin Pathways. 2022;8(4):8-11. Progression-Free Survival Associated With Olaparib With or Without Cediranibvs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer Study findings suggest that neither olaparib monotherapy...
J Clin Pathways....
05/20/2022
Journal of Clinical Pathways
Research in Review
Highlights from the Community Oncology Alliance (COA) 2022 Community Oncology Conference
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways. 2022;8(3):30-32. Addressing Disparities in Cancer Health, Equity, and Outcomes A panel at the 2022 Community Oncology Conference discussed how their programs address disparities in cancer care and access to cancer...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
Research in Review Focus on Lung Cancer
04/20/2022
JCP Editors
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways. 2022;8(3):21-23. Therapeutic Targeting of BAP1/ASXL3 Sub-Complex in SCLC Investigators sought to discover the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in small-cell lung cancer (SCLC) by developing a...
J Clin Pathways....
04/20/2022
Journal of Clinical Pathways
Research in Review
Reviewing the Latest Research on Multiple Myeloma
03/16/2022
JCP Editors
03/16/2022
Journal of Clinical Pathways
Research in Review
Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine
03/16/2022
JCP Editors
03/16/2022
Journal of Clinical Pathways
Research in Review
Highlights from the 63rd American Society of Hematology (ASH) Annual Meeting
02/15/2022
JCP Editors
02/15/2022
Journal of Clinical Pathways
Research in Review
Research in Review
06/21/2021
JCP Editors
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...
J Clin Pathways....
06/21/2021
Journal of Clinical Pathways
Research in Review
Research in Review
05/20/2021
JCP Editors
Treatment Patterns After EGFR-TKI and Platinum-Based Chemotherapy Discontinuation in Metastatic NSCLC Study results show that immunotherapy is the most common next line of therapy after discontinuation of an...
Treatment Patterns After EGFR-TKI and Platinum-Based Chemotherapy Discontinuation in Metastatic NSCLC Study results show that immunotherapy is the most common next line of therapy after discontinuation of an...
...
05/20/2021
Journal of Clinical Pathways
Research in Review
Research in Review
04/22/2021
JCP Editors
Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic A panel at the virtual ACCC 47th Annual Meeting & Cancer Center Business Summit shared real-world experiences on the impact of the...
Digital Care Delivery Models and Staffing Concerns Amidst the COVID-19 Pandemic A panel at the virtual ACCC 47th Annual Meeting & Cancer Center Business Summit shared real-world experiences on the impact of the...
...
04/22/2021
Journal of Clinical Pathways
JCP September/October 2024 Issue

Current Issue

October 2024
Volume 10
Issue 5
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Recent Stories

Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Scott Swain, PhD.
Videos
Navigating the FDA’s Guidance on Real-World Evidence: Insights, Expectations, and Future Trends in Clinical Trials
02/02/2024
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director of real-world evidence & regulatory science at Cardinal Health, provides context and shares insights on the FDA's recently released guidance on the use of real-world data and real-world evidence in...
Scott Swain, PhD, MPH, director...
02/02/2024
Journal of Clinical Pathways
News
Disparities in Palliative Care Access Highlighted in Nationwide Study of Deceased Lymphoma Patients
12/04/2023
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that deceased lymphoma patients receiving palliative care experience significantly lower total charges but no significant impact on adjusted length of stay. The research also highlights disparities in access, with...
Nationwide study reveals that...
12/04/2023
Journal of Clinical Pathways
The role of cost in pathways panel discussion at CPC & CBEx 2023.
News
The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs
10/12/2023
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC & CBEx 2023 included a panel on “The Evolving Role of Cost in Pathways: Cost of Care, Cost Avoidance, and Patient Costs,” where participants investigated factors beyond drug costs that affect the bottom line...
Sunday’s day of sessions at CPC...
10/12/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use